Alnylam Pharmaceuticals
ALNY
#1094
Rank
A$30.64 B
Marketcap
A$228.80
Share price
1.20%
Change (1 day)
-65.52%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company